FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
219015NDAJOURNEY001EMROSICAPSULE, EXTENDED RELEASE;ORALEQ 40MG BASEMINOCYCLINE HYDROCHLORIDE2024-11-01PrescriptionYes
213690NDAJOURNEY001ZILXIAEROSOL, FOAM;TOPICALEQ 1.5% BASEMINOCYCLINE HYDROCHLORIDE2020-05-28PrescriptionYes
212379NDAJOURNEY001AMZEEQAEROSOL, FOAM;TOPICALEQ 4% BASEMINOCYCLINE HYDROCHLORIDE2019-10-18PrescriptionYes
210361NDAJOURNEY001QBREXZACLOTH;TOPICALEQ 2.4% BASEGLYCOPYRRONIUM TOSYLATE2018-06-28PrescriptionYes
201922NDAJOURNEY001XIMINOCAPSULE, EXTENDED RELEASE;ORALEQ 45MG BASEMINOCYCLINE HYDROCHLORIDE2012-07-11DiscontinuedNo
002XIMINOCAPSULE, EXTENDED RELEASE;ORALEQ 67.5MG BASEMINOCYCLINE HYDROCHLORIDE2012-07-11DiscontinuedNo
003XIMINOCAPSULE, EXTENDED RELEASE;ORALEQ 90MG BASEMINOCYCLINE HYDROCHLORIDE2012-07-11DiscontinuedNo
004XIMINOCAPSULE, EXTENDED RELEASE;ORALEQ 112.5MG BASEMINOCYCLINE HYDROCHLORIDE2012-07-11DiscontinuedNo
005XIMINOCAPSULE, EXTENDED RELEASE;ORALEQ 135MG BASEMINOCYCLINE HYDROCHLORIDE2012-07-11DiscontinuedNo
018737NDAJOURNEY001EXELDERMCREAM;TOPICAL1%SULCONAZOLE NITRATE1989-02-28PrescriptionYes
018738NDAJOURNEY001EXELDERMSOLUTION;TOPICAL1%SULCONAZOLE NITRATE1985-08-30PrescriptionYes
009112NDAJOURNEY003EURAXLOTION;TOPICAL10%CROTAMITON1955-04-29PrescriptionYes
006927NDAJOURNEY001EURAXCREAM;TOPICAL10%CROTAMITON1949-07-06DiscontinuedNo